New patent expiration for Novartis drug UTIBRON
Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. It […]
Patent Expiration
Drug Patent Expirations for the Week of April 4, 2021
SEEBRI (glycopyrrolate) Novartis Patent: 7,229,607 Expiration: Apr 9, 2021 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of April 4, 2021 Read Post »
New patent expiration for Ferrer Internacional drug XEPI
Annual Drug Patent Expirations for XEPI Xepi is a drug marketed by Ferrer Internacional and is included in one NDA.
New patent expiration for Ferrer Internacional drug XEPI Read Post »
New patent expiration for Fresenius Medcl drug PHOSLO
Annual Drug Patent Expirations for PHOSLO Phoslo is a drug marketed by Fresenius Medcl and is included in two NDAs.
New patent expiration for Fresenius Medcl drug PHOSLO Read Post »
New patent expiration for Fresenius Medcl drug PHOSLO GELCAPS
Annual Drug Patent Expirations for PHOSLO+GELCAPS Phoslo Gelcaps is a drug marketed by Fresenius Medcl and is included in one
New patent expiration for Fresenius Medcl drug PHOSLO GELCAPS Read Post »
Drug Patent Expirations for the Week of March 28, 2021
ONPATTRO (patisiran sodium) Alnylam pharms inc Patent: 8,895,721 Expiration: Mar 30, 2021 See More … For more information on how
Drug Patent Expirations for the Week of March 28, 2021 Read Post »
New patent expiration for Alnylam Pharms drug ONPATTRO
Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one
New patent expiration for Alnylam Pharms drug ONPATTRO Read Post »
New patent expiration for Ucb Inc drug NEUPRO
Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA.
New patent expiration for Shionogi Inc drug DORIBAX
Annual Drug Patent Expirations for DORIBAX Doribax is a drug marketed by Shionogi Inc and is included in one NDA.
New patent expiration for Shionogi Inc drug DORIBAX Read Post »
